Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...